Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

HEXO Names New CEO As Cannabis Sector Shake-Ups Continue

By (Brenda O'Farrell/ MarketsOct 26, 2021 07:50
HEXO Names New CEO As Cannabis Sector Shake-Ups Continue
By (Brenda O'Farrell/   |  Oct 26, 2021 07:50
Saved. See Saved Items.
This article has already been saved in your Saved Items

C-suite shake-ups have been the emerging theme in the cannabis sector over the last few weeks. Almost everywhere you turn, top level executives and the large and aspiring-to-be-larger marijuana companies are coming and going.

Among the changes: a new CEO at HEXO (NASDAQ:HEXO) (TSX:HEXO) has been announced. Scott Cooper, the former CEO of Truss Beverage, an Ontario-based beverage maker, specializing in cannabis infused drinks, will be taking over the helm of HEXO, confirming the ouster of founder and now former CEO Sebastien St-Louis.

Truss is a relatively new joint venture that was created by HEXO and Molson Coors Brewing (NYSE:TAP) to market adult drinks in the emerging cannabis-infused product sector. HEXO has been making headlines of late, as it has focused on a number of key acquisitions, including the purchase of Redecan, 48Noth Cannabis and Zenabis Global (OTC:ZBISF).

But the move that led to St-Louis’s ousting was made in September, when the company's board of directors received an investor letter demanding the then-CEO resign. The reasoning: HEXO was being over-leveraged to acquire these cannabis companies.According to the terms of the deals, the ownership structure of HEXO shifted, making the disgruntled investor along with the owners of Redecan the largest stakeholders in HEXO.


HEXO's stock has dropped by about 44% over the past year, and about 11% since the letter was submitted to the company's board. In fact, shares have been on a steady decline since April. Yesterday, the stock closed at $1.70 on the NASDAQ, down almost 0.6% on the day.

Cresco Announces Deal To Buy Medical Weed Manufacturer

Officials with Cresco Labs (OTC:CRLBF) (CSE:CL), a US-based marijuana grower and manufacturer of a variety of cannabis products, just announced it has reached a deal to buy an expanding medical weed company, Laurel Harvest Labs.

Laurel Harvest is a vertically integrated medical cannabis grower and manufacturer based in Pennsylvania. The company is active in research into new medical applications for cannabis, and has partnered with Temple University in Philadelphia, which has a leading cannabis research facility.

The purchase deal, reportedly worth $80 million, is expected to close before the end of the current year.

CRLBF Weekly
CRLBF Weekly

Shares of Cresco Labs have seen modest gains for the cannabis sector in the last 12 months, increasing just over 6.5% during that time. Yesterday, the stock, which trades on the OTC markets in the US, closed at $7.90, down 1.5% on the day.

Cresco Labs reports its latest earnings on Nov. 11, before the opening bell.

Next Up: All Eyes On Canopy Results

On the earnings front, investors in the cannabis sector need to mark Nov. 5 on their calendars. That's when Canopy Growth (NASDAQ:CGC) (TSX:WEED) reports Q2 earnings. The cannabis giant will be releasing results for the period ending Sept. 30, ahead of the open.

Given its size, Canopy earnings often provide an indication of how the overall sector is performing. Its latest earnings will come in the wake of the announcement earlier this month that the Canadian grower has just struck a deal to buy the leading cannabis edible company in North America, the US-based Wana Brands. Investors will be interested to see if company officials release any plans or provide any indication of what they have in store as Canopy ventures deeper into the edibles market.

HEXO Names New CEO As Cannabis Sector Shake-Ups Continue

Related Articles

HEXO Names New CEO As Cannabis Sector Shake-Ups Continue

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email